AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey
Authors: Haq, IU Ramsay, LE Wallis, EJ Isles, CG Ritchie, LD Jackson, PR
Citation: Iu. Haq et al., Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey, HEART, 86(3), 2001, pp. 289-295
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
Authors: Sanmuganathan, PS Ghahramani, P Jackson, PR Wallis, EJ Ramsay, LE
Citation: Ps. Sanmuganathan et al., Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials, HEART, 85(3), 2001, pp. 265-271
Dysfunctional breathing and asthma - Panic disorder needs to be considered
Authors: Davies, SJC Jackson, PR Ramsay, LE
Citation: Sjc. Davies et al., Dysfunctional breathing and asthma - Panic disorder needs to be considered, BR MED J, 323(7313), 2001, pp. 631-631
Statins for primary prevention: at what coronary risk is safety assured?
Authors: Jackson, PR Wallis, EJ Haq, IU Ramsay, LE
Citation: Pr. Jackson et al., Statins for primary prevention: at what coronary risk is safety assured?, BR J CL PH, 52(4), 2001, pp. 439-446
Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation
Authors: Wallis, EJ Ramsay, LE Haq, IU Ghahramani, P Jackson, PR
Citation: Ej. Wallis et al., Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation, J HYPERTENS, 19(4), 2001, pp. 691-696
Prevention of stroke and transient ischaemic attack
Authors: Jackson, PR Wallis, EJ Ramsay, LE
Citation: Pr. Jackson et al., Prevention of stroke and transient ischaemic attack, LANCET, 358(9283), 2001, pp. 762-762
The MRC trial of treatment in mild hypertension
Authors: Lever, AF McInnes, GT Brennan, PJ Millar, JA Ramsay, LE
Citation: Af. Lever et al., The MRC trial of treatment in mild hypertension, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 97-126
Cost effectiveness of statins
Authors: Pickin, DM McCabe, CJ Ramsay, LE Payne, N
Citation: Dm. Pickin et al., Cost effectiveness of statins, HEART, 83(6), 2000, pp. 714-714
Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age
Authors: Jackson, PR Wallis, EJ Ramsay, LE
Citation: Pr. Jackson et al., Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age, BR MED J, 321(7261), 2000, pp. 637-638
Comparison of methods of estimating coronary risk - Authors did not use latest version of Sheffield table
Authors: Wallis, EJ Ramsay, LE Yikona, JINM Jackson, PR
Citation: Ej. Wallis et al., Comparison of methods of estimating coronary risk - Authors did not use latest version of Sheffield table, BR MED J, 321(7254), 2000, pp. 175-176
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population
Authors: Wallis, EJ Ramsay, LE Haq, IU Ghahramani, P Jackson, PR Rowland-Yeo, K Yeo, WW
Citation: Ej. Wallis et al., Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population, BR MED J, 320(7236), 2000, pp. 671-676
Management of hypertension - Reply
Authors: Ramsay, LE Williams, B Potter, JF Johnston, GD MacGregor, GA Poston, L Poulter, NR Russell, G
Citation: Le. Ramsay et al., Management of hypertension - Reply, BR MED J, 320(7234), 2000, pp. 579-580
Debate: at what level of coronary heart disease risk should a statin be prescribed?
Authors: Jackson, PR Ramsay, LE
Citation: Pr. Jackson et Le. Ramsay, Debate: at what level of coronary heart disease risk should a statin be prescribed?, CURR OP LIP, 11(4), 2000, pp. 357-361
Absolute and relative risk in hypertension
Authors: Ramsay, LE Wallis, EJ Yeo, WW Jackson, PR
Citation: Le. Ramsay et al., Absolute and relative risk in hypertension, HBK HYPERT, 20, 2000, pp. 43-56
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods
Authors: Haq, IU Ramsay, LE Jackson, PR Wallis, EJ
Citation: Iu. Haq et al., Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods, QJM-MON J A, 92(7), 1999, pp. 379-385
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment
Authors: Pickin, DM McCabe, CJ Ramsay, LE Payne, N Haq, IU Yeo, WW Jackson, PR
Citation: Dm. Pickin et al., Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment, HEART, 82(3), 1999, pp. 325-332
Is the Framingham risk function valid for northern European populations? Acomparison of methods for estimating absolute coronary risk in high risk men
Authors: Haq, IU Ramsay, LE Yeo, WW Jackson, PR Wallis, EJ
Citation: Iu. Haq et al., Is the Framingham risk function valid for northern European populations? Acomparison of methods for estimating absolute coronary risk in high risk men, HEART, 81(1), 1999, pp. 40-46
Thiazide diuretics in hypertension
Authors: Ramsay, LE
Citation: Le. Ramsay, Thiazide diuretics in hypertension, CLIN EXP HY, 21(5-6), 1999, pp. 805-814
British Hypertension Society guidelines for hypertension management 1999: summary
Authors: Ramsay, LE Williams, B Johnston, GD MacGregor, GA Poston, L Potter, JF Poulter, NR Russell, G
Citation: Le. Ramsay et al., British Hypertension Society guidelines for hypertension management 1999: summary, BR MED J, 319(7210), 1999, pp. 630-635
Policy based on Sheffield table fully satisfies authors' criteria
Authors: Ramsay, LE Wallis, EJ Haq, IU Jackson, PR Yeo, WW
Citation: Le. Ramsay et al., Policy based on Sheffield table fully satisfies authors' criteria, BR MED J, 318(7191), 1999, pp. 1140-1141
Guidelines for management of hypertension: report of the third working party of the British Hypertension Society
Authors: Ramsay, LE Williams, B Johnston, GD MacGregor, GA Poston, L Potter, JF Poulter, NR Russell, G
Citation: Le. Ramsay et al., Guidelines for management of hypertension: report of the third working party of the British Hypertension Society, J HUM HYPER, 13(9), 1999, pp. 569-592
Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients
Authors: Yeo, KR Yeo, WW Wallis, EJ Ramsay, LE
Citation: Kr. Yeo et al., Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients, BR J CL PH, 48(4), 1999, pp. 610-615
Factors affecting the acceptance of drug therapy to prevent myocardial infarction
Authors: Nicholson, K Ramsay, LE Haq, IU Wallis, EJ Ghahramani, P Jackson, PR Yeo, WW
Citation: K. Nicholson et al., Factors affecting the acceptance of drug therapy to prevent myocardial infarction, BR J CL PH, 47(5), 1999, pp. 580-580
Randomized trial of step-3 diet vs simvastatin therapy for reduction in risk of coronary heart disease
Authors: Haq, IU Minnis, R Wallis, EJ Palmer, R Yeo, WW Jackson, PR Ramsay, LE
Citation: Iu. Haq et al., Randomized trial of step-3 diet vs simvastatin therapy for reduction in risk of coronary heart disease, BR J CL PH, 47(5), 1999, pp. 597-598
Effect on ACE inhibitor cough of replacing the ACE inhibitor with losartan
Authors: Wallis, EJ Yeo, WW Jackson, PR Ramsay, LE
Citation: Ej. Wallis et al., Effect on ACE inhibitor cough of replacing the ACE inhibitor with losartan, BR J CL PH, 47(5), 1999, pp. 598-599
Risultati: 1-25 | 26-30